New

Medable

The AI engine Fit Assessment

Beta

Medable develops digital solutions for clinical trials and operates within the pharmaceutical industry, providing a platform that enhances trial execution.

Blurb

Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.

HQ Location

Palo Alto (United States)

Founded

2015

Employees

501 - 1000

Total funding raised

$506.64M

Funding Status

Series D, $304.00M, October 26, 2021

Medable is on a mission to get effective therapies to patients faster by dramatically reducing the time from therapeutic development to market realization with digital data capture and real-time analytics that remove the complexities of clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and soild data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Our platform allows patients, healthcare providers, clinical research organizations and pharmaceutical sponsors to work together as a connected and empowered team in clinical trials.